Review of the Basic and Clinical Pharmacology of Sulfobutylether-β-Cydodextrin (SBECD)
- 1 August 2010
- journal article
- review article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 99 (8), 3291-3301
- https://doi.org/10.1002/jps.22109
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Amphotericin B-Induced Renal Tubular Cell Injury Is Mediated by Na + Influx through Ion-Permeable Pores and Subsequent Activation of Mitogen-Activated Protein Kinases and Elevation of Intracellular Ca 2+ ConcentrationAntimicrobial Agents and Chemotherapy, 2009
- Methyl-β-cyclodextrin, a specific cholesterol-binding agent, inhibits melanogenesis in human melanocytes through activation of ERKArchiv für dermatologische Forschung, 2008
- CyclodextrinsToxicologic Pathology, 2008
- The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agentBritish Journal of Clinical Pharmacology, 2003
- Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation RegimensAntimicrobial Agents and Chemotherapy, 2002
- Intravenous ItraconazoleAnnals of Pharmacotherapy, 2001
- Safety of Parenteral Hydroxypropyl β‐CyclodextrinJournal of Pharmaceutical Sciences, 1995
- Protective effects of cyclodextrin sulphates against gentamicin-induced nephrotoxicity in the ratJournal of Pharmacy and Pharmacology, 1993
- The Effect of Parenterally Administered Cyclodextrins on Cholesterol Levels in the RatPharmaceutical Research, 1991
- The Pharmacokinetics of β-Cyclodextrin and Hydroxypropyl-β-cyclodextrin in the RatPharmaceutical Research, 1990